Drug · DIN 02480158
NUCEIVA
SINGLE-USE VIALS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 16, 2019; first marketed October 16, 2019.
- Drug Identification Number (DIN)
- 02480158
- Company (DIN owner)
- Evolus IncorporatedNewport Beach, California, United States
- Schedule
- Schedule D; Prescription
- Dosage form
- Powder For Solution
- Route
- Intramuscular
- Therapeutic class (ATC)
- Botulinum toxin M03AX01
- Class
- Human
- Record last updated
- August 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PRABOTULINUMTOXINA | 100 UNIT | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 16, 2018: NOC 21217New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “nuceiva”. A notice may cover another product or only some lots: read it to see what it covers.
- Counterfeit Nuceiva injectable drug seized from New You Spa in Vaughan, OntarioSeptember 6, 2022 · Drugs · Product safety - Unauthorized product